- Home
- MMYT vs PTGX Comparison
MMYT vs PTGX Comparison
Compare MMYT & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MMYT | PTGX |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.2B |
| IPO Year | 2010 | 2016 |
Fundamental Metrics
Financial Performance| Metric | MMYT | PTGX |
|---|---|---|
| Price | $56.20 | $82.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $106.33 | $99.20 |
| AVG Volume (30 Days) | ★ 2.5M | 570.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 404.32 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.47 | N/A |
| Revenue Next Year | $17.34 | $501.99 |
| P/E Ratio | $107.67 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $53.09 | $33.70 |
| 52 Week High | $113.85 | $96.54 |
Technical Indicators
Market Signals| Indicator | MMYT | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 32.43 | 47.59 |
| Support Level | $54.25 | $80.59 |
| Resistance Level | $58.22 | $83.40 |
| Average True Range (ATR) | 3.49 | 3.06 |
| MACD | 0.32 | 0.08 |
| Stochastic Oscillator | 21.13 | 37.21 |
Price Performance
Historical ComparisonAbout MMYT MakeMyTrip Limited
MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.